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Abstract:  Widespread applications of ZnO nanoparticles (NP) in sun-
blocking cosmetic products have raised safety concerns related to their 
potential transdermal penetration and resultant cytotoxicity. Nonlinear 
optical microscopy provides means for high-contrast imaging of ZnO NPs 
lending in vitro and in vivo assessment of the nanoparticle uptake in skin, 
provided their nonlinear optical properties are characterized. We report on 
this characterization using ZnO NP commercial product, Zinclear, mean-
sized 21 nm. Two-photon action cross-section of this bandgap material (Ebg 
= 3.37 eV, λbg = 370 nm) measured by two techniques yielded consistent 
results of  ( ) 2ph
ZnO ZnO ησ  = 6.2 ± 0.8 μGM at 795 nm, and 32 ± 6 μGM at 770 
nm per unit ZnO crystal cell, with the quantum efficiency of  ZnO η  = (0.9 ± 
0.2) %. In order to demonstrate the quantitative imaging, nonlinear optical 
microscopy images of the excised human skin topically treated with 
Zinclear were acquired and processed using 
( ) 2ph
ZnO σ  and  ZnO η values yielding 
nanoparticle concentration map in skin. Accumulations of Zinclear ZnO 
nanoparticles were detected only on the skin surface and in skin folds 
reaching concentrations of 800 NPs per μm
3. 
© 2011 Optical Society of America 
OCIS codes:  (160.2540) Fluorescent and luminescent materials; (160.4236) Nanomaterials; 
(170.3880) Medical and biological imaging; (180.4315) Nonlinear microscopy; (250.5230) 
Photoluminescence 
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1. Introduction 
ZnO nanomaterial affords a range of important applications due to its unique optical 
properties. The bulk properties of a wide direct band gap (3.37 eV at room temperature) and 
high exciton binding energy (60 meV) are appealing for a new generation ultraviolet (UV) 
optoelectronics, including light-emitting diodes, diode lasers and field emission displays. High 
third-order nonlinearity of ZnO attracts researchers toward development of prospective optical 
devices, such as optical switches and  optical phase conjugators [1]. In addition, the high 
optical absorption of ZnO in both UVA (spectral ranges 400 nm to 315 nm) and UVB (315 
nm to 280 nm) is widely utilized in cosmetics for UV screening to protect against the 
radiation damage of skin. The use of ZnO nanoparticles (NP) in modern sunscreen 
formulations allows uniform coverage of skin  surface, and renders sunscreen transparent 
improving overall aesthetic appeal. The cosmetic industry push toward further improvements 
in sunscreen transparency leads to reduction of ZnO particles mean-size  below 20 nm, 
although this is tempered by the safety concerns associated with ZnO NP penetration in skin 
[2]. Application of ZnO-based sunscreen is generally regarded safe, if the nanomaterial stays 
on the skin surface, or is confined in stratum corneum (SC), the uppermost layer of skin. 
Despite SC is only about 10-40 μm thick (with a notable exception of palms of hands and 
soles of feet), it provides superb protection against environmental assault, which is due to its 
material-tight structure comprised dried flattened cells, corneocytes, cemented together by a 
lipid bilayer [3,4]. The next underlying skin layer, termed viable epidermis, contains viable 
cells, which are susceptible to toxicological hazards associated with extraneous nanomaterials. 
The toxicological risks of ZnO nanomaterial in viable epidermis is hotly debated, whereas 
cytotoxic effects of ZnO NP have been proven in epithelial cells, neural stem cells and various 
types of immune cells [5–9]. It is, therefore, consented that it is best to avoid penetration of 
ZnO NPs into viable epidermis and deeper skin layers. Hence, assessment of ZnO NP 
concentration in skin, including SC, viable epidermis and deeper dermal layers  of skin 
becomes an important research focus in cosmetics, dermatology, and nanotoxicology [2,7,10–
14]. 
A number of techniques have been demonstrated for assaying of skin nanomaterial 
absorption in skin. Among these, radiolabelling, cathodoluminescence and Franz cell assaying 
[15,16]. These techniques are, however, limited to in vitro  studies. Electron 
microscopy/spectroscopy methods provide detailed morphological information at the 
nanometer-scale, but suffer from potential distortion of the skin transport properties. Besides, 
the associated skin preparation procedure is tedious and costly. Analysis of the NP 
distribution in SC by tape stripping methods have been demonstrated to be reasonably 
accurate assaying of metal oxide nanoparticle distribution in skin layers, although being 
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analysis of nanoparticle distribution in skin, nonlinear optical microscopy (NLOM) has 
demonstrated a considerable promise, as an in vivo imaging modality capable of providing 
clear images of the subsurface skin layers (at a depth of ≤ 200 μm in turbid biological tissue) 
at the sub-cellular resolution [19–21]. In particular, NLOM imaging has revealed in vivo that 
topically applied ZnO NPs mean-sized ~20 nm stayed in SC and accumulated in skin folds 
and hair follicles [10]. ZnO NP appeared to exhibit high NLOM-imaging contrast on the 
intense autofluorescence background of live skin. Partly, it was due to the excitation 
wavelength, 740 nm, at which the imaging penetration depth was maximized, as the tissue 
scattering and absorption were minimized [22]; and also due to the emission wavelength at 
385 nm, where the two-photon-excited skin tissue autofluorescence was relatively low [23]. 
Quantitative evaluation of the ZnO-nano distribution in skin, however, remains a challenge 
due to the non-reproducible laser excitation conditions, such as the pulse width variation, and 
variable nonlinear properties of ZnO nanomaterial. This challenge is addressed in this paper. 
Ample literature is devoted to characterization of nonlinear optical properties of ZnO bulk 
[24–26], and, recently, ZnO nanomaterials, which are mainly governed by the 2nd- [χ
(2)] and 
3rd- [χ
(3)] order electric susceptibilities. χ
(2) is responsible for the second-harmonic generation 
(SHG) processes in ZnO bulk and nanomaterials [27,28], whereas the imaginary part of χ
(3) 
governs the two-photon-absorption-induced  photoluminescence  (TPIL).  Although  Im[χ
(3)] 
does not capture the full spectral content of ZnO photoluminescence (PL), due to the effects 
of impurity-induced energy states in the bandgap, it lends an initial interpretation of TPIL 
principle UV spectral band emission centered at 385 nm. At the nanoscale, ZnO properties are 
found to deviate from these of bulk. The quantum confinement effects result in a blue-shift of 
the absorption and emission bands of ZnO NP of diameters < 5 nm, and also account for the 
emission enhancement [29]. At the same time, the quantum effects alone fail to explain an 
approximately hundred-fold emission enhancement in case of ZnO NP of diameter > 10 nm, 
invoking impurity-  or surface-  mediated  excitation processes, whose mechanisms are still 
under research highlight [30]. TPIL is of prime interest in the NLOM imaging of ZnO NP, 
with an SHG contribution at the smaller scale. It is important to note that the use of Im[χ
(3)] is 
not favored by the biomedical optics convention that gives preference to a linearly-related 
quantity of a two-photon action cross-section, 
( ) 2ph
ZnO ZnO ησ  defined as a product of the quantum 
efficiency,  ZnO η  (a ratio of emitted to absorbed photon  energies) and the two-photon 
absorption cross-section,  ( ) 2ph
ZnO σ . 
Among several techniques used for determination of the two-photon absorption cross-
section, Z-scan is most popular and conceptually straightforward [31–33]. In brief, a focused 
(short-pulse) probe beam is axially scanned through a sample eliciting two types of nonlinear 
optical interactions that predominantly occur at the focal volume. Light-induced refractive 
index  variation  governed  by  Re[χ
(3)] results in a detectable lensing effect. Two-photon 
absorption governed by Im[χ
(3)] removes photons from the probe beam, which is detectable 
and  separable  from  the  Re[χ
(3)]-related  effect.  Determination  of  χ
(3)  of bulk and 
microcrystalline ZnO have been reported by using this technique [34]. However, the Im[χ
(3)]-
related removal of photons in colloidal suspensions of ZnO NPs is superimposed on the 
elastic scattering exacerbated by often occurring NP aggregation (cf. data shown in Fig. 1) 
[31]. Besides, ZnO nanomaterial synthesis can yield low-concentration colloids whose 
Im[χ
(3)]-effect on the probe beam is difficult to detect. An alternative approach of measuring 
( ) 2ph
ZnO σ relies on counting PL photons versus controlled ZnO sample excitation parameters, 
where  ZnO η  is determined separately [30]. The high sensitivity of this method is underpinned 
by the single-photon detection limit of modern photodetectors. Besides, 
( ) 2ph
ZnO σ measurement is 
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femtoliters. 
In this paper, we report on a systematic study of ZnO NP nonlinear optical properties, with 
a two-fold aim: (1) addressing two characterization techniques suitable for determination of 
the two-photon action cross-section, and (2) establishing a numerical correspondence between 
the nonlinear optical microscopy signal of ZnO NP and nanoparticle distribution in skin, 
which paves a way for quantitative in vivo nanotoxicology studies. 
2. Materials and method 
2.1. Material description 
Commercially available formulation Zinclear_60CCT (Antaria Ltd., WA, Australia) was used 
for characterization. The original formulation contained 60% ZnO NPs in organic solvent 
capric/caprylic triglyceride (CCT), in addition to poly-fatty acid, as the hyper-dispersant. 
Primary mean-size of ZnO nanoparticles was specified as 20 nm. The NPs were produced via 
mechanochemical  technology, which allowed large-scale fabrication. Nanoscale ZnO was 
synthesized by milling and heat treatment of the  mixture of ZnCl2, NaCl and Na2CO3 
powders. Particle size was controlled by means of the reactant chemical ratio, milling time 
and heat treatment temperature. ZnO NP was then coated with stearic acid to render the 
surface hydrophobic to facilitate dispersion in silicone-based non-polar liquids, as in cosmetic 
formulations [35]. The resultant ZnO NPs were ellipsoidal in shape characterized by high 
crystal quality, as shown in Fig. 1. 
2.2. Characterization 
In order to determine physical properties of the as-received material, which contained 
ingredients used for topical application on human skin in cosmetic formulations and skin 
uptake experiments, size distribution of ZnO NP was measured by the dynamic light 
scattering method (DLS, Malvern Zetasizer ZS, UK) after dilution with original solvent CCT. 
Fluorometer (Fluorolog Tau3 system, JY Horiba) was employed to measure the 
photoluminescence (PL) spectra of ZnO NP. Due to the intrinsic fluorescence of CCT, ZnO 
NPs were subsequently extracted from CCT and distilled in deionized water (DDW). ZnO NP 
absorption spectra were measured using UV/Vis spectrometer (Carry 5000, Varian). In order 
to minimize the scattering effect, the suspension was placed in a 2-mm pathway high-grade 
UV quartz cuvette. In the concentration range of our study, the scattering mean-path is much 
greater than the pathway of the cuvette, so it can be regarded as a single scattering event. 
Besides, the scattering cross-section of ZnO NPs was small compared with the absorption 
cross-section, and can  be neglected. The sample PL quantum yield was determined by 
comparison of the linear (as opposed to nonlinear) emission to absorption ratio with respect to 
that of tabulated organic fluorescence dye, Stilbene 1, using controlled concentration of both 
samples, as detailed in Results. 
Primary size of ZnO NPs was determined by using transmission electron microscopy 
(TEM). ZnO NPs were extracted from the Zinclear_60CCT in acetone, then dried out on a 
clean glass slide. The collected powder was redispersed in ethanol at a concentration of 0.01 - 
0.1 mM (defined in terms of the ZnO crystal unit cell), and imaged using TEM (Philips 
CM10). 
ZnO NP hydrodynamic mean-diameter (yielding ~10% overestimate of its physical size) 
was determined via DLS by using 0.1-mM and 1-mM solutions in various solvents, including 
DDW, ethanol, methanol, acetone, and CCT. 15-min sonication of the samples was carried 
out prior to these measurements. 
We used two methods to evaluate the two-photon absorption cross-section of ZnO NP. 
Method 1 was an absolute measurement developed by Kauert et al., which involved a flow 
cell and a TPSPC measurement module (Becker and Hickl) [36]. The wavelength was fixed to 
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nonlinear optical signal using the nonlinear optical microscopy setup. The wavelength-tunable 
femtosecond laser in NLOM system was set to 770 nm to attain the maximum contrast ratio of 
ZnO NP signal versus skin autofluorescence, as detailed in Subsection 3.3. 
2.3. PVA nanoscale thin film fabrication 
For the NLOM-based determination of  ( ) 2ph
ZnO ZnO ησ , it was essential to prepare a film with 
uniform distribution ZnO NPs. Spin-coating method was employed, with polyvinyl alcohol 
(PVA), as a host polymer. By mixing 10% PVA w/w water solution with pre-dispersed ZnO 
NP solutions 1:1 volume ratio, films of various ZnO concentrations were fabricated. A 90-nm 
thin film was deposited on a coverslip (thickness, 170 μm) by spin-coating PVA for 1 min at a 
speed of 8000 rpm, followed by drying in an oven at 40°C overnight allowing 99% of the 
solvent (water) to be evaporated. The surface smoothness and the degree of homogeneity were 
evaluated by a scanning electron microscope (SEM, JEOL 6480 LA). The film thickness was 
determined by an optical profiler (WYKO NT 3000) via measuring a step profile at the 
interface of film-glass substrate. 
2.4. Skin sample preparation 
Human skin patches were excised from, predominantly, female donors aged between 30 and 
40 years (n = 3) who had undergone abdominoplasty surgery. All experiments conducted on 
human subjects were carried out with the approval of Princess Alexandra Hospital Human 
Ethics Research Committee (Approval no. 097/090, administrated by the University of 
Queensland Human Ethics Committee), and the subjects gave their written consents. 10 μL of 
the 60% w/w Zinclear formulation in the CCT solvent was applied on the 1.33 cm
2 skin 
human skin patches, which were fixed in a standard Franz cell and incubated at a 37°C-warm 
water bath. The application dose was slightly higher than that recommended for daily 
application (2 mg/cm
2) according to the  Food and Drug Administration (FDA) and the 
international protocols. The formulation was massaged into the skin surface for 5 min, prior to 
incubation at 37°C, and washed off after 8 hours of incubation. 
The treated human skin samples were encased in polyether wax and cut into 8-μm-thin 
cross-section slices followed by sandwiching between standard microscopy glass slides and 
coverslips, which were ready for NLOM imaging. 
2.5. Microscopy 
Experiment configuration 
A nonlinear optical microscopy system (Leica DM IRBE/TCS SP2) was employed for 
imaging of the ZnO NP-treated human skin samples. A tunable titanium-sapphire 
femtosecond-pulsed laser (Tsunami, Spectra Physics), pumped by a 5-Watt CW laser 
(Millennia, Spectra Physics) was employed, as the excitation source. The laser wavelength 
was set to 770 nm. The laser pulse width was evaluated as < 150 fs, at a repetition rate of 80 
MHz, the spectral bandwidth was measured to be ~10 nm, average power at the sample, 70 
mW. The laser beam was focused in the sample by a high-NA, oil-immersion microscope 
objective (40× , NA 1.3). 
TPIL-signal excited by the laser was collected by the objective lens and passed through a 
filter cube that comprised a 700-nm short-pass filter to block the excitation at 770 nm, 
followed by a bandpass dichroic mirror 390 ± 40 nm. The filtered UV-emission of ZnO NP 
was detected by using a photomultiplier tube; while two-photon-induced autofluorescence 
signals of the skin tissue (broad emission centered at 550 nm) was suppressed [23]. 
An UV diode laser (405 nm) excitation was employed to acquire skin morphology by 
collecting autofluorescence signal of the skin endogenous fluorophores, such as NAD(P)H, 
flavins, collagen, elastin, and melanin (the filter cube filter was tuned to a spectral band of 
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respectively, and overlaid to display ZnO NP distribution in skin. The quantitative imaging 
will be interpreted in more detail in the Results and discussion Subsection 3.4. 
The acquired images were processed by Igor Pro (Wavemetrics) software. SC was 
manually delineated in each image allowing a purpose-designed software code to calculate the 
direction normal to the skins surface at each point. This was used to flatten the skin surface 
along one axis (x-axis), while setting a perpendicular y-axis along the in-depth direction in 
skin. The sum of the y-profiles were averaged over every TPIL image, and over all images to 
obtain  the ZnO NP distribution in-depth profile, while the autofluorescence signals were 
averaged using the same algorithm to produce the skin profile. 
3. Results and discussion 
3.1. Size determination 
The Zinclear_60CCT size dispersion was determined in the as-received organic solvent of 
caprylic capric triglyceride (Sample 1), and in either water, or alcohol, or acetone (Sample 2). 
Sample 1 was well-dispersed and stable due to its hydrophobic surface coating, which 
rendered NPs water-repellent and dispersible in non-polar organic solvents, such as CCT. In 
addition, the surface coating modified the chemical stability and decreased the photocatalysis 
by surface passivation. Figure 2 shows reasonably monodisperse size distribution of Sample 1 
(mean hydrodynamic diameter, 35 nm, FWHM 15 nm) measured by DLS in the diluted 
original CCT solution. A subtle peak in the size-range of 60 - 120 nm was an indication of the 
aggregation, which was removable by sonication. Sample 2 exhibited aggregation, which was  
 
 
Fig. 1. A high-magnification TEM image of the well-dispersed ZnO NPs (Sample 1) displaying 
single particles (left inset); and ZnO grain size histogram (left panel). A low-magnification 
TEM image of Sample 2 (right inset), with a size distribution histogram showing NP 
aggregations (right panel). Solid (blue) line represent the size distribution fit to a Gaussian 
function used to determine the distribution mean-size and standard deviation. 
 
Fig. 2. Size distribution of the Zinclear (ZnO NP) sample measured by DLS: Sample 1, as-
received ZnO NPs in CCT organic solvent, square symbol; the  blue line,  represents a 
distribution of primary sizes. Sample 2, redispersed in acetone, triangle symbol; the red line 
represents an agglomerated state. 
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retained their granularity, as observable in TEM images (Fig. 1(a)). The aggregate size 
distribution was consistent and relatively narrow, 160 ± 30 nm (Fig. 2, red curve). Note that 
the hydrodynamic diameter provides an approximately 10% size overestimate of the physical 
diameter, as measured by TEM (Fig. 1, insets). 
TEM afforded accurate sizing of the Samples. High-magnification TEM images were 
captured to examine the granular content of the Sample 1, which was statistically analyzed to 
produce a size distribution histogram, as shown in Fig. 1(a). Low-magnification TEM images 
captured aggregation size properties of Sample 2. Figure 1(b) shows a representative image, 
with the aggregation mean-size of 150 nm corroborating the DLS measurement results. 
3.2. Linear spectral properties of ZnO NP 
Photoluminescence quantum yield (η) is an important parameter of an emitter defined as a 
percentage value of the emitted photon energy per one absorbed photon energy. η of ZnO NP 
was determined by comparing emission/absorption ratio of Sample 2 of the molar 
concentration (in terms of ZnO unit cells) 1 mM to that of the organic fluorescence dye 
Stilbene 1 (Sb1). Sb1 concentration was maintained at 0.05 mM throughout all measurements 
as a trade-off between maximized fluorescence signal and onset of the self-quenching effects. 
A representative absorbance [defined as –log10(It/I0),  where  I0  and  It  are  incident and 
transmitted intensities, respectively] spectra of the 1-mM Sample 2 and 0.05-mM Sb1 are 
shown in Fig. 3. The spectrum of ZnO NP is characterized by a strong absorption in an UV 
band extending considerably into the UV-range, with a local absorption peak at 362 nm, 
whereas Sb1 absorption is characterized by a relatively narrower spectral band centered at 350 
nm. Peak absorbances of Sample 2 and Sb1 were measured to be 1.34 and 1.27, respectively 
(Fig. 3). 
 
Fig. 3. (a) Absorption spectrum of 1-mM Zinclear_60CCT, Sample 2, redispersed in acetone; 
(b) absorbance spectrum of 0.05-mM Sb1 dissolved in ethylene glycol. 
 
Fig. 4. Emission spectra of (a) ZnO-NP (varied concentration, excitation wavelength, 310 nm), 
The pure ethanol emission spectrum was used, as a baseline (solid black line); and (b) Stilbene 
1 (0.05 mM, solvent, ethylene glycol), excitation wavelength, 350 nm. 
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compared with these of Sb1, excited at 350 nm to achieve maximum quantum efficiency (Fig. 
4). The concentration-dependent red-shift of the ZnO-NP emission peak was attributed to the 
self-absorption. 
In order to determine the quantum yield of the ZnO NP sample,  ZnO η , one needs to ratio 
emitted to absorbed intensities, respectively. The absorbed intensity is determined in terms of 
absorbance by using the Beer-Lambert law: 
  ( ) ( ) 10 0 10 log log , M A I I e lC ε = −=    (1) 
where A is the measured absorbance, ε [cm
−1.M
−1] is the molar absorptivity of the sample, l is 
the pathway length, and CM [M, or mol/L] is the molar concentration. The emitted PL power 
is determined as 
  , M P CI ξηε =    (2) 
where I is the averaged excitation intensity taking into account the beam attenuation in the 
sample; ξ  - collection efficiency, which is an instrumentation parameter, assumed equal for 
both ZnO NP and Sb1 samples. By relating the emitted power of ZnO NP to that of the Sb1 
sample, integrated over the equal spectral bands, one finds a quantum yield ratio given by 
 
1 11
.
ZnO ZnO ZnO
Sb Sb Sb
PA
PA
η
η
=    (3) 
1 Sb η was reported to be 0.56, allowing straightforward calculation of the percentage value of 
ZnO η  = (0.9 ± 0.2)%. This value is comparable with the reported values [10,37]. 
3.3. Two-photon action cross-section 
The first method for determining the two-photon action cross-section of ZnO,  ( ) 2ph
ZnO ZnO ησ  has 
been described in detail by Kauert et al. [36]. Briefly, ZnO NP suspension was injected into a 
flow cell and illuminated by a focused, 795-nm ultrashort-pulse laser system (Mira 900 
pumped by Verdi V10, Coherent) of the pulse width of 130 fs and average power ranging 
from 3 to 30 mW, with an TPIL signal being recoded versus the illumination (excitation) 
power. Rhodamine 6G (Rh:6G) dissolved in ethanol was used, as the calibration standard. The 
method ability to count single TPIL events allowed accurate determination of the detected 
fluorescence or PL power, i.e. either a single Rh:6G molecule, or a well-defined single 
aggregate of ZnO NP. Also, this method afforded the substantial excitation laser power, as the 
photo-degraded molecules/NPs in the flow were quickly replenished. In addition, the single-
photon counting technique allowed measurement of the TPIL decay time by using a TPSPC 
measurement module. An example of the TPIL single-photon correlation dependence that 
related to PL time trajectory is shown in Fig. 5(a). The ZnO NP decay curve was fitted by two 
exponentials, with a short component of τ1 = 139 ps, associated with emission in the UV/blue 
spectral band, and a long component, τ2 = 3.1 ns, associated with ZnO NP emission in the 
green spectral band. The green emission is commonly attributed to oxygen-defects in the bulk 
crystal and/or oxygen surface defects [27]. The longer TPIL decay component reported by the 
others was not detectable using our set up [12].  Figure 5(b)  shows a log-log plot of the 
emission intensity versus the incident power. The slope of the fitted line is ≌2, which 
indicated that the two-photon absorption process played a major role [25]. 
The two-photon action cross-section was calculated by using the following formula [36]: 
 
( )
( ) 2
* ,
ph
TPIL ZnO Rh Rh Rh
ZnO ZnO
Rh ZnO
TPIL C
TPIL C
ησ
ησ =    (4) 
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Rh, ZnO for Rh:6G and Zinclear ZnO NP samples, respectively); TPIL stands for the detected 
signals. We note that the two-photon action cross-section of an agglomerate (demarcated by 
an asterisk in the subscript) was determined. It was recalculated as  ( ) 2ph
ZnO ZnO ησ  for a single 
crystal unit cell of ZnO to be 6.2 ± 0.8 μGM, using ZnO density of 5.6 g/cm
3 and molecular 
weight of 81.41 g/mole. The single crystal unit cell was defined to contain one pair of Zn and 
O ion (ZnO dimer) for the purpose of comparison convenience. 
 
Fig. 5. (a) Time-resolved single-photon correlation signal of ZnO NP showing fast and slow 
decay components. Data fit, red line. (b) Log-log plot of the power dependence of ZnO NP on a 
scale (×, blue line). The data is linear-fit (solid red line), with a fitted slope of 2. 
It was straightforward to evaluate the two-photon action cross-section of 1.19 GM per 
primary particle of 20.6 nm in size estimating Nu.c. = 1.9 × 10
5 unit cells per particle. While 
aggregation was present in the solution, the optical absorption from the ZnO was small. It is 
worthwhile to provide 
( ) 2
..
ph
u c ZnO ZnO N ησ per single primary particle for comparison with the other 
reported values, where the aggregation was not considered. Also, Zinclear formulation 
represented a well-dispersed suspension of the primary particles in CCT oil, largely retaining 
its quasi-monodispersity, when applied topically on human skin [12], so that the detected 
TPIL signal should be linearly related to  ( ) 2
..
ph
u c ZnO ZnO N ησ  providing a direct primary particle 
distribution read out in human skin. 
The second method used to determine  ( ) 2ph
ZnO σ was based on the calibrated-throughput 
nonlinear optical microscopy. The simplicity of this method was appealing, but traded off by 
the potential accuracy inferior to that of the first method. Thin PVA films (thickness, 90 nm) 
of Sb1 and ZnO NP at various concentrations were NLOM-imaged, multiple images were 
acquired for each concentration, and the average intensity over all images was calculated. The 
microscope operation parameters were maintained constant during the image acquisition, 
except that the twice greater femtosecond laser power was used to illuminate the ZnO NP 
samples in comparison with the Sb1 samples. To remove artifacts arising from fluctuations in 
the microscope system and detector photoresponsivity for each image, a second image was 
acquired, with the laser switched off, referred to as the background, B, and its average value 
was subtracted from the initial image (signal, S). 
The resultant TPIL signal was averaged over the ZnO-NP/PVA-film sample field of view, 
to minimize the effects of the ZnO NP aggregation, assuming that the self-absorption effect 
remained negligible in the 90-nm-thin film. Scanning electron microscopy (SEM) of the ZnO-
NP/PVA-film confirmed that a quasi-single layer of particles was observable and their sub-
micron features were discernable.
( ) 2ph
ZnO σ was calculated by using the following equation: 
  ( ) 2 2,
ph
ZnO ZnO N S B CI ξη σ −=    (5) 
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collection efficiency parameter, ξ  from  Eq. (5), one needed to benchmark the ZnO TPIL 
signal against that of the tabulated fluorophore, such as Sb1. S-B vs. CN data were acquired 
experimentally and graphed in Fig. 6. An TPIL signal slope of Sb1, defined as Slope = (S-
B)/CN was determined to be 3.4 × 10
6 arb. un. (arbitrary units) using the data plotted in Fig. 
6(b). The reported value of two-photon absorption cross-section of Sb1 is 
50 4 12.1 10 m s/photon.particle
− × (12.1 GM), with the quantum yield of 0.56 [38]. 
 
Fig. 6. TPIL emission signal versus concentration of: (a) ZnO and (b) Sb1. The data were fitted 
with straight lines. For ZnO NP, the signal saturated at the higher concentrations, due to the 
self-absorption, the lower limit was set by the detection sensitivity. 
The TPIL signal slope of ZnO NP is given by 
  ( ) 2 2 4,
ph
ZnO ZnO ZnO Slope I ξη σ =    (6) 
Since the two-photon action cross-section is linearly proportional to the two-photon 
absorption cross-section, with a proportionality constant being the quantum efficiency of the 
emitter, the quantum efficiency was assumed invariant over the process order and spectral 
range [39]. With  ZnO η  = 9 × 10
−3, as described in 3.2, and the factor of 4 accounting for the 
twice greater excitation power in comparison with that of Sb1. SlopeZnO was determined to be 
55.3 arb. un. using the data plotted in Fig. 6(a) that yielded  ( ) 2ph
ZnO σ  = 4 mGM and  ( ) 2ph
ZnO ZnO ησ  = 
32 ± 6 μGM per ZnO dimer, which corresponded to  ( ) 2
..
ph
u c ZnO N σ  = 700 GM and  ( ) 2
..
ph
u c ZnO ZnO N ησ  
= 6 GM per a primary particle. The estimated error of 25% was due to the non-reproducibility 
of the sample preparation procedure and uncontrollable detection parameters, such as the 
femtosecond laser pulsewidth, estimated using the assumption of the Fourier-limited 
transform of the spectral bandwidth. 
A reasonable agreement was found between the two different presented methods, with the 
discrepancy attributed to the different excitation wavelengths. The excitation centered at 770 
nm, was effectively on the falling slope of the ZnO NP excitation curve (cf. Figure 3(a) at 385 
nm), whereas the excitation centered at 795 nm, was well outside of the ZnO NP excitation 
band. The excitation of ZnO NP still took place due to the finite spectral bandwidth (FWHM 
~10 nm) of the femtosecond laser in both methods, but the excitation efficiency was 
apparently greater at 770 nm, which was  reflected in the corresponding values of 
( ) 2ph
ZnO σ . 
Comparison with the previously reported results shows  that  ( ) 2ph
ZnO σ  per unit cell of the 
investigated ZnO NP sample, Zinclear is an order of magnitude greater than  ( ) 2ph
ZnO σ  
recalculated from the measured value of Im[χ
(3)] of ZnO NP at the excitation wavelength of 
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crystal quality of ZnO NPs evidenced by very little PL in the green spectral band (cf. Figure 
4(a)) than that of the sol-gel method used in Ref. [25]. Also, the excitation spectral band at 
532 nm in comparison with that of 770 nm was irrelevant to NLOM-based studies biomedical 
studies. We also note that the determined ZnO NP two-photon action cross-section, 6 GM, 
was markedly higher than that of the skin-dominant endogenous fluorophores, < 0.1 GM at 
700 nm [40], thus explaining the high-contrast images of ZnO NP/skin obtained in Ref. [10]. 
The conventional nonlinear optical microscopy appeared to be capable of determining the 
nonlinear properties of optical nanomaterials. By knowing
( ) 2ph
ZnO ZnO ησ , one can determine ZnO 
nanoparticle concentration in (biological) samples by using TPIL signals, as demonstrated in 
the final subsection. 
3.4. Quantitative assessment of ZnO NP uptake in skin 
Using the calibrated NLOM system, as detailed above, the tissue slices of ZnO-NP-treated 
skin were imaged. ZnO NP concentration was measured in terms of particles per cubic micron 
by using Eq. (5) and the calibration curve of ZnO NP versus pixel signal intensity on image. 
Using our developed quantitative imaging method, distribution of ZnO NPs in the epidermis 
of the excised human skin sample was assessed. An in-house developed algorithm was used to 
process the NLOM cross-sectional images, as shown in Fig. 7(a), such that the skin surface 
was unfolded into a straight line lending accurate determination of the ZnO NP distribution in 
epidermis, as plotted in Fig. 7(b). Figure 7(a) shows a cross-section morphology of the skin 
sample rendered visible by the autofluorescence excited by a 405-nm laser, detected in the 
visible spectral band, and color-coded green. One can observe (left to right) dermis layer, 
bright-green viable epidermis layer populated by cells, with discernible dark round nuclei, and 
a faint layer of SC, with a white contour roughly outlining the sample boundary. TPIL ZnO 
NP signals are color-coded red, and observable in SC, especially, two conspicuous clusters, 
but not in viable epidermis. Some traces of red color-coded signals in the dermis layer were 
attributed to SHG signals from the collagen fibers. 
 
Fig. 7. (a) An overlay of the confocal/multiphoton image of the excised human skin, and (b) 
plot of the ZnO NP distribution versus the skin depth processed from the image data. Left 
panel: green color, skin autofluorescence excited by 405 nm; red color, ZnO NP distribution in 
skin (stratum corneum) excited by 770 nm, with collagen-induced faint SHG signals in the 
dermal layer. Yellow arrows point to ZnO NP clusters. Right panel: ZnO NP concentration in 
the epidermis. A threshold line (dashed, blue) delineates spurious signals due to the image 
processing artifacts (below the line) from the ZnO NP signals. The right-hand-side axis, ZnO 
NP concentration per unit length averaged across the entire imaged skin surface. 
It was found that the 21-nm primary-size ZnO NPs exhibited small absorption in stratum 
corneum, with no detectable absorption in viable epidermis, which was consistent with the 
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occasional protrusion to the areas of dermatoglyphs (skin folds). Figure 7(b)  shows an 
averaged skin autofluorescence profile (green solid line) plotted together with ZnO NP signal 
(red area graph). The autofluorescence profile maximum demarcates the onset of the viable 
epidermis, which fades away slowly toward the deeper skin layers. Firstly, this data allowed 
direct assessment of the ZnO NP absorption in skin, where the signal was seen to be 
accumulated on the surface and in SC, possibly, in dermatoglyphs. Secondly, and most 
importantly, direct read-out of ZnO NP concentration was obtained reaching about 800 
particles per μm
3 at the depth of the conspicuous cluster localization. The right-hand y-axis of 
this plot also provided a quantitative read-out of the ZnO NP concentration per sample unit 
length, as averaged over the entire skin tissue sample. 
4. Conclusion 
We investigated the physical and optical properties of typical commercial ZnO NPs, Zinclear. 
In the organic solvent, ZnO NPs remained dispersed, with a mean diameter of 21 nm, whereas 
in polar solvents, e.g. water, alcohol, the nanoparticles were gradually aggregated to a mean-
diameter of ~200 nm. Characterization of the sample optical properties yielded a 
photoluminescence quantum yield of (0.9 ± 0.2)%. A two-photon action cross-section 
measured by the two nonlinear optical microscopy based methods, provided 6.2 ± 0.8 μGM at 
795 nm, and 32 ± 6 μGM at 770 nm, which was considerably greater than the values of the 
dominant endogenous fluorophores in biological tissue. 
We have also demonstrated a method of quantitative assessment of ZnO NP distribution 
profile in human skin suitable for non-invasive measurements in vivo. ZnO NP distribution 
peaking at the concentration value of 800 particles per μm
3 was located at the topmost layer of 
skin, stratum corneum and in skin folds, with no detectable signal in viable epidermis. The 
reported investigations are believed to be enabling for in vivo  nanotoxicology studies 
considering the granted ethic clearance for ZnO-formulations. 
Acknowledgment 
One of us (Z. S.) wishes to acknowledge Macquarie University postgraduate research funding 
supporting this work. 
 
#156151 - $15.00 USD  Received 7 Oct 2011; revised 6 Nov 2011; accepted 8 Nov 2011; published 15 Nov 2011
(C) 2011 OSA 1 December 2011 / Vol. 2,  No. 12 / BIOMEDICAL OPTICS EXPRESS  3333